A novel treatment modality for the treatment of COPD is presented. A patient story in which a patient was brought from a pulmonary capacity of 25% to a pulmonary capacity of 44% over a series of 13 treatments is presented. The patient in question had a concomitant improvement in quality of life that is hitherto unheard of in this patient category. This study was neither planned nor theorized. On the contrary, it came about due to a patient query that caught me by surprise. Where she was before the treatment unable to carry out many activities of daily living without assistance, she was after the treatment able to carry out nearly all her activities of daily living without assistance. A case for the dissemination of this effective treatment is made. Low level laser therapy definitely has its place in the treatment of any inflammatory process for which reason it is clearly relevant in the COPD sphere. Experience of the author in related fields is shortly presented as well as the political and financial aspects discussed. There is no doubt that low level laser therapy will enjoy much further dissemination in the years to come, and this article is a step in that direction.
| Published in | Journal of Family Medicine and Health Care (Volume 7, Issue 4) |
| DOI | 10.11648/j.jfmhc.20210704.14 |
| Page(s) | 105-107 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
Chronic Obstructive Pulmonary Disease, Low Level Laser Therapy, Cost of Disease
| [1] | Szalontai K, Gémes N, Furák J, et al. Chronic obstructive pulmonary disease: epidemiology, biomarkers, and paving the way to lung cancer. 2021 J Clin Med, 10 (13): pUblished online witout page numbers. |
| [2] | Ritchie AI, Wedzicha JA. Definition, causes, pathogenesis, and consequences of chronic obstructive pulmonary disease exacerbations. 2020 Clin Chest Med, 41 (3): pp. 421-438. |
| [3] | Tipton MJ, Harper A, Paton JFR, Costello JT. The human ventilatory response to stress: rate or depth? 2017 J Physiol. 595 (17), pp. 5729-5752. |
| [4] | Tselebis A, Pachi A, Ilias I, et al. Strategies to improve anxiety and depression in patients with COPD: a mental health perspective. Feb 9. 2016 Neuropsychiatric Treat., Neuropsychiatr Dis Treat: pp. 297-328. |
| [5] | Løkke a, Hiberg O, Tønesen P, Ibsen R, Kjellberg J, Jennnum P Direct and indirect economic and health consequenses of COPD in Denmark: a national register-based study. 1998-2010. 2014 London British Medical Journa. 6 (4): pp. 237-246. |
| [6] | Chan SMH, Selemidis S, Bozinovski S, Vlahos R. Pathobiological mechanisms underlying metabolic syndrome (MetS) in chronic obstructive pulmonary disease (COPD): clinical significance and therapeutic strategies. 2019 Pharmacol Ther. Vol 198: pp. 160-188. |
| [7] | Clark E, Tedford I, Scott DeLapp I, Steven J, Anders J. Quantitative analysis of trnascranial and intraparanchymal light penetration in human cadaver brain tissue. 2015 Lasers in Surgery and Medicine. 47 (4): pp. 312-322. |
| [8] | Sayed MA, El-Sherif BM, Mohammed AR et al. Low-level laser therapy in chronic obstructive lung disease. 2018 Egyptian Journal of Bronchology. Vol. 12. pp. 317-322. |
| [9] | Steele RE Low level laser therapy and myofasical pain. 2020. New York, New York. Journal of pain mangement. 13 (1): pp. 56-62. |
| [10] | Perrera J The 'healing laser' comes into the limelight. In: Riegel RJ, Godbold JC, eds. 1987, Laser therapy in veterinary medicine, pp. 1-6. |
| [11] | Gaitonde R, Oxman AD, Okebukola PO, Rada G Interventions to reduce corruption in the health sector Cochrane, 2016, Vol 8 Cochrane Database Syst Rev, pp. 1-77. |
| [12] | Steele RE, Carpenter DO, de Leeuw E. A Novel and effetive treatment modality for medically unesplained pain. 2009 New York, New York. Journal of Pain Managemen. 1 (4): pp. 401-412. |
| [13] | Foa EB, Gillihan SJ, Bryant RA Challenges and Successes in Dissemination of Evidence-Based Treatments for Posttraumatic Stress: Lessons Learned From Prolonged Exposure Therapy for PTSD. 2013, Psychol Sci Public Interest, 14 (2), pp. 65-111. |
APA Style
Richard Evan Steele. (2021). Low Level Laser Therapy and Chronic Obstructive Pulmonary Disease. Journal of Family Medicine and Health Care, 7(4), 105-107. https://doi.org/10.11648/j.jfmhc.20210704.14
ACS Style
Richard Evan Steele. Low Level Laser Therapy and Chronic Obstructive Pulmonary Disease. J. Fam. Med. Health Care 2021, 7(4), 105-107. doi: 10.11648/j.jfmhc.20210704.14
AMA Style
Richard Evan Steele. Low Level Laser Therapy and Chronic Obstructive Pulmonary Disease. J Fam Med Health Care. 2021;7(4):105-107. doi: 10.11648/j.jfmhc.20210704.14
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.jfmhc.20210704.14,
author = {Richard Evan Steele},
title = {Low Level Laser Therapy and Chronic Obstructive Pulmonary Disease},
journal = {Journal of Family Medicine and Health Care},
volume = {7},
number = {4},
pages = {105-107},
doi = {10.11648/j.jfmhc.20210704.14},
url = {https://doi.org/10.11648/j.jfmhc.20210704.14},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.jfmhc.20210704.14},
abstract = {A novel treatment modality for the treatment of COPD is presented. A patient story in which a patient was brought from a pulmonary capacity of 25% to a pulmonary capacity of 44% over a series of 13 treatments is presented. The patient in question had a concomitant improvement in quality of life that is hitherto unheard of in this patient category. This study was neither planned nor theorized. On the contrary, it came about due to a patient query that caught me by surprise. Where she was before the treatment unable to carry out many activities of daily living without assistance, she was after the treatment able to carry out nearly all her activities of daily living without assistance. A case for the dissemination of this effective treatment is made. Low level laser therapy definitely has its place in the treatment of any inflammatory process for which reason it is clearly relevant in the COPD sphere. Experience of the author in related fields is shortly presented as well as the political and financial aspects discussed. There is no doubt that low level laser therapy will enjoy much further dissemination in the years to come, and this article is a step in that direction.},
year = {2021}
}
TY - JOUR T1 - Low Level Laser Therapy and Chronic Obstructive Pulmonary Disease AU - Richard Evan Steele Y1 - 2021/12/24 PY - 2021 N1 - https://doi.org/10.11648/j.jfmhc.20210704.14 DO - 10.11648/j.jfmhc.20210704.14 T2 - Journal of Family Medicine and Health Care JF - Journal of Family Medicine and Health Care JO - Journal of Family Medicine and Health Care SP - 105 EP - 107 PB - Science Publishing Group SN - 2469-8342 UR - https://doi.org/10.11648/j.jfmhc.20210704.14 AB - A novel treatment modality for the treatment of COPD is presented. A patient story in which a patient was brought from a pulmonary capacity of 25% to a pulmonary capacity of 44% over a series of 13 treatments is presented. The patient in question had a concomitant improvement in quality of life that is hitherto unheard of in this patient category. This study was neither planned nor theorized. On the contrary, it came about due to a patient query that caught me by surprise. Where she was before the treatment unable to carry out many activities of daily living without assistance, she was after the treatment able to carry out nearly all her activities of daily living without assistance. A case for the dissemination of this effective treatment is made. Low level laser therapy definitely has its place in the treatment of any inflammatory process for which reason it is clearly relevant in the COPD sphere. Experience of the author in related fields is shortly presented as well as the political and financial aspects discussed. There is no doubt that low level laser therapy will enjoy much further dissemination in the years to come, and this article is a step in that direction. VL - 7 IS - 4 ER -
Email: